Colorectal cancer (CRC) is among the most lethal and prevalent malignancies in the world
and was responsible for nearly 881,000 cancer-related deaths in 2018. Surgery and …

Colorectal cancer (CRC) is the third most common type of cancer and the second leading
cause of cancer deaths worldwide. Surgery or surgery plus radiotherapy and/or …

Treatment strategies for metastatic colorectal cancer (mCRC) patients have undergone
dramatic changes in the past decade and despite improved patient outcomes, there still exist …

Colorectal cancer (CRC) is the third most common cancer type and the second cause of
death worldwide. The advancement in understanding molecular pathways involved in CRC …

Background: Several molecular targeting agents are available and being used in patients
with colorectal cancer, and many others are being tested clinically. Methods: The authors …

Colorectal cancer (CRC) is the third most diagnosed malignancy and a major leading cause
of cancer-related deaths worldwide. Despite advances in therapeutic regimens, the number …

Nowadays, colorectal cancer is the fourth most common type of tumor all over the world.
When diagnosed,∼ 50%–60% of tumors have metastasized, thus resulting in a grim …

Colorectal cancer (CRC) affects 1 in 23 males and 1 in 25 females, making it the third most
common cancer. With roughly 608000 deaths worldwide, CRC accounts for 8% of all cancer …

Despite a decrease in incidence and mortality, colorectal cancer (CRC) still represents the
second leading cause of cancer worldwide. Recurrence following surgery and adjuvant …

Treatment algorithms and survival for patients with metastatic colorectal cancer have
changed dramatically over the past decade, largely due to the advent of molecularly …